Equities

AbbVie Inc

0QCV:LSE

AbbVie Inc

  • Price (USD)221.50
  • Today's Change6.25 / 2.90%
  • Shares traded5.15k
  • 1 Year change15.59%
  • Beta0.3402
Data delayed at least 20 minutes, as of Feb 06 2026 19:09 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year AbbVie Inc had little change in net income (from 4.28bn to 4.23bn) despite revenues that grew 8.57% from 56.33bn to 61.16bn.
Gross margin71.16%
Net profit margin4.02%
Operating margin15.16%
Return on assets1.73%
Return on equity138.53%
Return on investment2.46%
More ▼

Cash flow in USDView more

In 2024, cash reserves at AbbVie Inc fell by 7.29bn. However, the company earned 18.81bn from its operations for a Cash Flow Margin of 33.38%. In addition the company used 20.82bn on investing activities and also paid 5.21bn in financing cash flows.
Cash flow per share6.08
Price/Cash flow per share35.98
Book value per share-1.49
Tangible book value per share-52.39
More ▼

Balance sheet in USDView more

SmartText is unavailable
Current ratio0.7245
Quick ratio0.5992
Total debt/total equity--
Total debt/total capital1.04
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)3.98%
Div growth rate (5 year)8.00%
Payout ratio (TTM)496.51%
EPS growth(5 years)-14.67
EPS (TTM) vs
TTM 1 year ago
-53.76
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.